Clinical Trial Update: Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the safety and immune response of the West Nile virus vaccine WN/DEN4-3'delta30 in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• West Nile Encephalitis
• West Nile Fever

Drugs mentioned

• WN/DEN4-3'delta30 vaccine (West Nile virus vaccine WN/DEN4-3'delta30)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: West Nile Fever Encephalitis | Phase 1 | Status: COMPLETED